Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN108640917B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108640917B reveals a novel Rh-catalyzed one-pot synthesis for indolo isoquinoline intermediates, offering significant supply chain and cost advantages.
Novel Rh-catalyzed one-pot synthesis of indolo[2,1-a]isoquinolines using sulfur ylides. Efficient route for pharmaceutical intermediates with mild conditions.